thiorphan has been researched along with Chronic Disease in 3 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic diarrhea is a frequent and challenging problem in clinical medicine." | 2.48 | Functional diarrhea. ( Tack, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tack, J | 1 |
| Mishima, T | 1 |
| Tanimura, M | 1 |
| Suzuki, G | 1 |
| Todor, A | 1 |
| Sharov, VG | 1 |
| Tanhehco, EJ | 1 |
| Goldstein, S | 1 |
| Sabbah, HN | 1 |
| Petrie, MC | 1 |
| Hillier, C | 1 |
| Johnston, F | 1 |
| McMurray, JJ | 1 |
1 review available for thiorphan and Chronic Disease
| Article | Year |
|---|---|
Functional diarrhea.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Bismuth; Carbon; Cholestyramine Resin; Chronic Dis | 2012 |
2 other studies available for thiorphan and Chronic Disease
| Article | Year |
|---|---|
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Topics: Animals; Chronic Disease; Coronary Angiography; Dogs; Heart Failure; Hemodynamics; Myocytes, Cardiac | 2002 |
Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure.
Topics: Adrenomedullin; Antihypertensive Agents; Arteries; Chronic Disease; Dose-Response Relationship, Drug | 2001 |